Trivant Custom Portfolio Group’s Elevance Health ELV Stock Holding History

Trivant Custom Portfolio Group’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-6,579	Closed	-$2.86M	–	130
2025 Q1	$2.86M	Buy	6,579 +342	+5%	+$137K	1.65%	21
2024 Q4	$2.3M	Sell	6,237 -81	-1%	-$33.9K	1.34%	25
2024 Q3	$3.29M	Buy	6,318 +28	+0.4%	+$15K	1.9%	22
2024 Q2	$3.41M	Sell	6,290 -34	-0.5%	-$18K	2.09%	16
2024 Q1	$3.28M	Sell	6,324 -182	-3%	-$90.5K	2.09%	18
2023 Q4	$3.07M	Sell	6,506 -98	-1%	-$45.3K	2.05%	18
2023 Q3	$2.88M	Buy	6,604 +20	+0.3%	+$9.07K	2.11%	16
2023 Q2	$2.93M	Buy	6,584 +82	+1%	+$37.8K	2.06%	15
2023 Q1	$2.99M	Buy	+6,502	New	+$3.09M	2.14%	13

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Trivant Custom Portfolio Group's ELV Position: Q2 2025 in Review

Trivant Custom Portfolio Group sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 6,579 shares — an estimated $2.86M sold.

Trivant Custom Portfolio Group first reported a position in ELV in Q1 2023 and held it in 9 quarters. The position peaked at $3.41M in Q2 2024. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

Trivant Custom Portfolio Group reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
Trivant Custom Portfolio Group sold 6,579 Elevance Health shares in Q2 2025, an estimated $2.86M.
Trivant Custom Portfolio Group first reported a position in Elevance Health in Q1 2023 and held it in 9 quarters.
Trivant Custom Portfolio Group's Elevance Health position peaked at $3.41M in Q2 2024.
1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Trivant Custom Portfolio Group's 13F filing for Q2 2025, filed 12 Aug 2025.